ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 51,563 shares of ACADIA Pharmaceuticals stock in a transaction that occurred on Friday, October 6th. The stock was sold at an average price of $21.96, for a total transaction of $1,132,323.48. Following the completion of the sale, the chief executive officer now owns […]
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $3.62-$4.11 for the period, compared to the consensus estimate of $3.97. The company issued revenue guidance of $425.00 million-$445.00 million, compared to the consensus revenue estimate of $442.97 million. Analysts Set […]
JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) traded up 6.8% during trading on Thursday . The stock traded as high as $10.11 and last traded at $10.11. 100 shares were traded during mid-day trading, a decline of 60% from the average session volume of 250 shares. The stock had previously closed at $9.47. […]
StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research note published on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently issued reports on the company. Jonestrading reiterated a hold rating on shares of TRACON Pharmaceuticals in […]
ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) was downgraded by equities researchers at Leerink Partnrs from an “outperform” rating to a “market perform” rating in a research note issued on Thursday, PriceTargets.com reports. Other equities analysts also recently issued research reports about the company. William Blair cut ARS Pharmaceuticals from an “outperform” rating to a […]